drugset / Trial / NCT01170806

Study of Fat Malabsorption by Lipiblock Versus Xenical

NCT01170806

RandomizedCrossoverDouble-blindBasic science

Summary

Obesity is a chronic condition with fat-rich diets playing a major role in its etiology. Pharmacological therapy has been proposed for weight loss and maintenance. This study aims to study the intestinal lipase blockade by partial inhibition of fat absorption after treatment with two commercials formulations of Orlistat.

Timeline

Start
2009-10
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Orlistat Small molecule 120 mg Oral

Indications